Viewing Study NCT02879760


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-03-06 @ 8:46 AM
Study NCT ID: NCT02879760
Status: COMPLETED
Last Update Posted: 2020-10-06
First Post: 2016-08-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients
Sponsor: Turnstone Biologics, Corp.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module